Exclusive biopharma, health policy, and life science analysis. Start your 30-day free trial today.

Catch up on the latest must-read coverage and analysis

advertisement

Most Popular

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
Newest Omicron Covid-19 lineages gaining ground in United States
Facebook is receiving sensitive medical information from hospital websites
Verily co-founder lays out vision for how real-world data can transform health care
Girl’s case of lupus leads to new understanding of a perplexing disease

FDA oversight of pharma manufacturing facilities plunges during the pandemic
A widely anticipated ALS drug wouldn’t be cost effective if priced the same as an older rival
Quantity over quality: FDA approved more cancer drugs than EMA, but they may not have always benefited patients

advertisement

Events

How Tech Can — and Can’t — Eliminate Barriers to Good Health Care Jun. 29, 2022
Democrats’ Last Chance for Drug Pricing Reform? Jul. 20, 2022
STATUS List Spotlights Series: Admiral Rachel L. Levine Jul. 26, 2022

See More Events

STAT Reports

Deep-dive reports into the breakthroughs that are revolutionizing health care.

The need for speed and safety: A primer on the FDA’s drug approval pathways
Continuous glucose monitoring: how it’s advancing diabetes care
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry

See More Reports